+36.1%
MRNA vs TRGP
+260.3%
-224.2%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | TRGP | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -0.6% | +5.9% | +5.4% |
| 7D | -1.1% | +0.1% | -1.2% | -1.1% |
| 30D | +126.1% | +8.0% | +118.1% | +124.9% |
| 3M | +190.0% | +8.3% | +181.8% | +187.8% |
| 6M | +157.2% | +23.9% | +133.3% | +149.2% |
| YTD | +388.2% | +59.6% | +328.6% | +351.7% |
| 1Y | +467.0% | +79.4% | +387.6% | +414.8% |
| 3Y | +36.1% | +269.4% | -233.4% | +30.5% |
| All | +36.1% | +260.3% | -224.2% | +30.5% |
Cumulative growth
Daily Returns
Daily percentage return beside TRGP.
Daily Out/Under-Performance
Portfolio return minus TRGP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × TRGP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded TRGP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling